Merrimack Pharma (MACK) Reports Q2 Loss of $0.03
Tweet
Share
E-mailGet Alerts MACK Hot Sheet
Join SI Premium – FREE
Merrimack Pharma (NASDAQ: MACK) reported Q2 EPS of ($0.03).
For earnings history and earnings-related data on Merrimack Pharma (MACK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
